Quotation Estimate Medical Researcher in Germany Munich –Free Word Template Download with AI

This Quotation Estimate is issued by HelixGen Research Solutions GmbH to formally outline the projected costs, deliverables, and professional services associated with the engagement of a qualified Medical Researcher for a Phase III clinical research programme in the field of neurodegenerative disorders. All services described herein will be executed within the jurisdiction of Germany Munich, in full compliance with the German Medical Research Act (Arzneimittelgesetz – AMG), the German Data Protection Act (BDSG), and the European General Data Protection Regulation (GDPR). This Quotation Estimate serves as a binding financial projection for a period of ninety (90) calendar days from the date of issue, after which all listed rates and conditions are subject to revision.

HelixGen Research Solutions GmbH proposes the full-time engagement of a senior Medical Researcher (MD, PhD) with a minimum of twelve (12) years of post-doctoral experience in neurology and clinical pharmacology. The Medical Researcher will be based at the primary research facility in Germany Munich and will perform the following core duties:

• Design and oversight of the Phase III clinical trial protocol for a novel neuroprotective agent, including statistical power analysis and endpoint selection.
• Coordination of multi-centre data collection across three (3) secondary research sites within the Munich metropolitan area and the broader Bavarian region.
• Authorship and peer-review submission of at least two (2) original research articles in internationally indexed journals (IF > 5.0) during the contract period.
• Regulatory liaison with the Paul-Ehrlich-Institut (PEI) and the local ethics committee (Ethikkommission) in Munich to ensure continuous compliance with all applicable German and EU research regulations.
• Supervision of a team of four (4) junior research assistants and two (2) laboratory technicians assigned to the project in Germany Munich.
• Monthly progress reporting to the client's steering committee, including interim safety data reviews and adverse event documentation.

All amounts stated in this Quotation Estimate are denominated in Euro (EUR) and are subject to the standard 19% German value-added tax (Mehrwertsteuer). Payment shall be made via bank transfer (SEPA) to the account of HelixGen Research Solutions GmbH, IBAN: DE89 3704 0044 0532 0130 00, BIC: COBADEFFXXX, within thirty (30) calendar days of invoice date. Invoices will be issued on a monthly basis, reflecting the actual services rendered by the Medical Researcher and the supporting team during the preceding calendar month. A 1.5% monthly late-payment interest will apply to overdue balances in accordance with § 288 of the German Civil Code (BGB).

1. This Quotation Estimate is valid for a period of ninety (90) days from the date of issue. Upon expiry, all rates, scope definitions, and conditions must be reconfirmed in writing by both parties.
2. The engagement of the Medical Researcher is governed by a separate Service Agreement (Dienstleistungsvertrag) to be executed prior to the commencement of any research activities in Germany Munich.
3. All research data, intellectual property, and publication rights generated during the course of this project shall vest exclusively in the client, Bayerische Universitätsklinikum GmbH, unless otherwise stipulated in the Service Agreement.
4. HelixGen Research Solutions GmbH shall maintain full professional liability insurance (Berufshaftpflichtversicherung) with a minimum coverage of EUR 5,000,000 per claim throughout the duration of the contract.
5. Any changes to the scope of work, additional research sites, or extended timelines must be documented in a written change order signed by both parties before implementation. Revised costs will be reflected in a supplementary Quotation Estimate.
6. Both parties agree to resolve any disputes arising from this Quotation Estimate or the subsequent Service Agreement through mediation, followed by binding arbitration under the rules of the Arbitration Institute of the German Chamber of Commerce (DIS) in Munich, Germany.
7. This Quotation Estimate does not constitute a contract until formally accepted in writing by the client and countersigned by HelixGen Research Solutions GmbH.

By signing below, the client acknowledges receipt of this Quotation Estimate and agrees to the terms, conditions, and financial projections outlined herein for the engagement of a Medical Researcher and associated services in Germany Munich.